Chronulac and Vertigo aggravated - a phase IV clinical study of FDA data

Summary:

Vertigo aggravated is reported as a side effect among people who take Chronulac (lactulose), especially for people who are female, 60+ old, also take Zofran, and have Constipation.

The phase IV clinical study analyzes which people have Vertigo aggravated when taking Chronulac. It is created by eHealthMe based on reports of 359 people who have side effects when taking Chronulac from the FDA, and is updated regularly.

What is Chronulac?

Chronulac has active ingredients of lactulose. eHealthMe is studying from 360 Chronulac users. Check the latest studies of Chronulac.

What is Vertigo aggravated?

Vertigo aggravated is found to be associated with 2,500 drugs and 714 conditions by eHealthMe. Check the latest studies of Vertigo aggravated.

On Jul, 25, 2026

359 people reported to have side effects when taking Chronulac.
Among them, 16 people (4.46%) have Vertigo aggravated.

Could Chronulac cause Vertigo aggravated?

Among these 16 people:

What is the gender of people who have Vertigo aggravated when taking Chronulac? *

female: 81.25 %
male: 18.75 %

What is the age of people who have Vertigo aggravated when taking Chronulac? *

What are other drugs people take besides Chronulac? *

What are other side effects people have besides Vertigo aggravated? *

High Blood Pressure: 8 people, 50.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 43.75%
Fatigue (feeling of tiredness): 7 people, 43.75%
Peripheral Swelling: 6 people, 37.50%
Appetite Disorder (abnormal eating habits): 5 people, 31.25%
Headache (pain in head): 5 people, 31.25%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 5 people, 31.25%
Depression: 4 people, 25.00%
Pain: 4 people, 25.00%
Rashes (redness): 4 people, 25.00%

What are the existing conditions these people have? *

Constipation: 4 people, 25.00%
Abdominal Discomfort: 3 people, 18.75%
Depression: 3 people, 18.75%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 3 people, 18.75%
Asthma: 3 people, 18.75%
Metastases To Lung (cancer spreads to lung): 2 people, 12.50%
Malignant Neoplasm Of Ampulla Of Vater (cancer tumour of union of the pancreatic duct and the common bile duct): 2 people, 12.50%
Hepatitis C: 2 people, 12.50%
Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 2 people, 12.50%
Acute Lymphocytic Leukaemia (In Remission): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Chronulac and have Vertigo aggravated?

- Check whether Vertigo aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Chronulac:

Chronulac (360 reports)

Browse all side effects of Chronulac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vertigo aggravated:

Vertigo aggravated (2,501 drugs)

Browse all the conditions that are associated with Vertigo aggravated:

Vertigo aggravated (714 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lactulose (the active ingredients of Chronulac) and Chronulac (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.